Suppr超能文献

与显性造血克隆相关的逆转录病毒载体插入位点标记了“干性”通路。

Retroviral vector insertion sites associated with dominant hematopoietic clones mark "stemness" pathways.

作者信息

Kustikova Olga S, Geiger Hartmut, Li Zhixiong, Brugman Martijn H, Chambers Stuart M, Shaw Chad A, Pike-Overzet Karin, de Ridder Dick, Staal Frank J T, von Keudell Gottfried, Cornils Kerstin, Nattamai Kalpana Jekumar, Modlich Ute, Wagemaker Gerard, Goodell Margaret A, Fehse Boris, Baum Christopher

机构信息

Department of Experimental Hematology, Hannover Medical School, Germany.

出版信息

Blood. 2007 Mar 1;109(5):1897-907. doi: 10.1182/blood-2006-08-044156. Epub 2006 Nov 21.

Abstract

Evidence from model organisms and clinical trials reveals that the random insertion of retrovirus-based vectors in the genome of long-term repopulating hematopoietic cells may increase self-renewal or initiate malignant transformation. Clonal dominance of nonmalignant cells is a particularly interesting phenotype as it may be caused by the dysregulation of genes that affect self-renewal and competitive fitness. We have accumulated 280 retrovirus vector insertion sites (RVISs) from murine long-term studies resulting in benign or malignant clonal dominance. RVISs (22.5%) are located in or near (up to 100 kb [kilobase]) to known proto-oncogenes, 49.6% in signaling genes, and 27.9% in other or unknown genes. The resulting insertional dominance database (IDDb) shows substantial overlaps with the transcriptome of hematopoietic stem/progenitor cells and the retrovirus-tagged cancer gene database (RTCGD). RVISs preferentially marked genes with high expression in hematopoietic stem/progenitor cells, and Gene Ontology revealed an overrepresentation of genes associated with cell-cycle control, apoptosis signaling, and transcriptional regulation, including major "stemness" pathways. The IDDb forms a powerful resource for the identification of genes that stimulate or transform hematopoietic stem/progenitor cells and is an important reference for vector biosafety studies in human gene therapy.

摘要

来自模式生物和临床试验的证据表明,基于逆转录病毒的载体随机插入长期重建造血细胞的基因组中,可能会增加自我更新或引发恶性转化。非恶性细胞的克隆优势是一种特别有趣的表型,因为它可能是由影响自我更新和竞争适应性的基因失调引起的。我们从小鼠长期研究中积累了280个逆转录病毒载体插入位点(RVISs),这些研究导致了良性或恶性克隆优势。RVISs(22.5%)位于已知原癌基因内部或附近(最多100 kb[千碱基]),49.6%位于信号基因中,27.9%位于其他或未知基因中。由此产生的插入优势数据库(IDDb)与造血干/祖细胞的转录组和逆转录病毒标记的癌症基因数据库(RTCGD)有大量重叠。RVISs优先标记在造血干/祖细胞中高表达的基因,基因本体论显示与细胞周期控制、凋亡信号传导和转录调控相关的基因过度表达,包括主要的“干性”途径。IDDb为鉴定刺激或转化造血干/祖细胞的基因提供了强大的资源,是人类基因治疗中载体生物安全性研究的重要参考。

相似文献

引用本文的文献

本文引用的文献

5
Genotoxicity of retroviral integration in hematopoietic cells.逆转录病毒整合在造血细胞中的基因毒性。
Mol Ther. 2006 Jun;13(6):1031-49. doi: 10.1016/j.ymthe.2006.03.001. Epub 2006 Apr 19.
10
Foamy virus vector integration sites in normal human cells.泡沫病毒载体在正常人类细胞中的整合位点。
Proc Natl Acad Sci U S A. 2006 Jan 31;103(5):1498-503. doi: 10.1073/pnas.0510046103. Epub 2006 Jan 20.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验